AGENUS INC Operating Leases, Future Minimum Payments, Due Thereafter
AGENUS INC (AGEN) had Operating Leases, Future Minimum Payments, Due Thereafter of $928.00 thousand as of 2018-12-31, per its 10-Q filed 2019-11-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter · last filed 2019-11-07
- 2018-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $928.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $2.47M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $3.87M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $7.89M.
| Period end | Operating Leases, Future Minimum Payments, Due Thereafter |
|---|---|
| 2018-12-31 | $928.00K 10-Q · filed 2019-11-07 |
| 2017-12-31 | $2.47M 10-K · filed 2018-03-16 |
| 2016-12-31 | $3.87M 10-K · filed 2017-03-16 |
| 2015-12-31 | $7.89M 10-K · filed 2016-03-15 |
| 2014-12-31 | $5.29M 10-K · filed 2015-03-16 |
| 2013-12-31 | $6.96M 10-K · filed 2014-03-07 |
| 2012-12-31 | $8.53M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |